Showing papers in "Archives of Cardiovascular Diseases in 2017"

TL;DR: Experimental studies indicate that some pollutants have more harmful cardiovascular effects, such as combustion-derived PM2.5 and ultrafine particles, and promotion of safer air quality appears to be a new challenge in cardiovascular disease prevention.

TL;DR: A better understanding of the conditions underlying pulmonary hypertension is of key importance to establish a comprehensive diagnosis, leading to an adapted treatment to reduce heart failure morbidity and mortality.

TL;DR: Recruitment was in line with expectations and the first data show that management has continued to evolve since the 2010 survey, with continued improvement in hospital outcomes.

TL;DR: The effect of colchicine on inflammation in the context of STEMI could not be demonstrated, and further larger studies may clarify the impact of col chicine in acute myocardial infarction.

TL;DR: Aside from the two main predictors of arrhythmia (symptoms and spontaneous electrocardiogram pattern), many risk factors have been recently suggested for stratifying risk of sudden cardiac death in Brugada syndrome and current guidelines are discussed.

TL;DR: The aim of this review is to emphasize the cardiac side effects caused by serotonin receptor activation, and to highlight their possible prevention by the development of new drugs targeting this system.

TL;DR: Education during adolescent-to-adult transition has a significant impact on health knowledge and structured CHD educational programmes could improve understanding and prevent potential future complications.

TL;DR: 3D TTE using new-generation fully automated software is a feasible, fast, reproducible and accurate imaging modality for LV volumetric quantification in routine practice.

TL;DR: New data have provided a better understanding of atherosclerosis, enabling us to see calcification as a marker of the state of stability or instability of the atherosclerotic plaque, and opening new perspectives for atheroscerotic plaque imaging.

TL;DR: It is of great importance to try to include the evaluation of right ventricular strain as a regular part of each echocardiographic examination in patients with heart failure, however, further investigations are necessary to establishright ventricular strains as a standard variable for decision-making.

TL;DR: Outcomes are poor in ES, but seem better with PAH-SDT, and ES with pretricuspid defects has worse outcomes despite the delayed disease onset.

TL;DR: The authors' series of patients with CS who received steroids alone or combined with immunosuppressive therapy had a good prognosis, with an overall 5-year survival rate of 92 and the recovery rate was 85, with no significant difference between patients treated with steroids Alone or plus immunos Puppressive therapy.

TL;DR: The question of appropriate dosing has become important, as studies are starting to show that reduced doses are being prescribed at very high rates and recent results have shown that only certain risk criteria justify dose reduction.

TL;DR: Cardiac surgery is feasible in low-income countries with acceptable in-hospital mortality and proof of capacity building and patient outcomes after cardiac surgery inLowincome countries remain unknown, given the strikingly high numbers of lost to follow-up.

TL;DR: Among the patterns of LV geometry in AS, LVCR portends the worst outcome, and patients with LVCR and AS have a considerable increased risk of mortality, regardless of clinical management.

TL;DR: The findings suggest that the Carpreg score is the most appropriate predictor of maternal complications, although the stratification might be improved.

TL;DR: It is now possible to safely decrease the number of contraindicated dental procedures in patients at risk of endocarditis, and the decision for implant placement should follow an analysis of general and local factors increasing the risk of implant failure.

TL;DR: The rationale for DCB use, and the effectiveness of DCBs in different clinical and lesion settings, are discussed, and practical tips for their correct use in everyday clinical practice are given.

TL;DR: HF is emerging as a leading cause of morbidity and mortality in the ACHD population and earlier diagnosis and more active management are required to improve outcomes of HF in ACHd.

TL;DR: There is currently no recommended indication for prophylactic implantable cardioverter defibrillator implantation-except maybe in the case of multiple risk factors-while radiofrequncy ablation may be proposed in secondary prevention with or even without a back-up implantable cardiac defibrillsator in selected cases.

TL;DR: CA can safely address macroreentrant MVT in repaired TOF patients with an acceptable long-term rate of recurrence in this high-risk population.

TL;DR: The LASP can be a site for thrombus formation, leading to embolic events, but its presence does not correlate with an increased incidence of stroke, and Associated factors should be taken into consideration in the setting of stroke.

TL;DR: LAAC using an ACP device followed by single antiplatelet therapy could be a reasonable alternative for stroke prevention and was found to be less frequent than expected.

TL;DR: The results suggest a much higher prevalence of CAD in HFpEF/HFmEF than previously reported and should encourage clinicians to aggressively identify this co-morbidity.

TL;DR: The potential mechanisms of radiation-induced right ventricular remodelling are still unclear, but it is thought that fibrosis is the dominant factor in myocardial remodelling and vascular changes.

TL;DR: The rate of statin discontinuation, overall and in each cardiovascular risk group, was greater in 2013 after the media event than in previous years and the clinical impact of the increased discontinuation could be important.

TL;DR: At the beginning of NOAC prescriptions, European doctors tended to switch from VKAs to NOACs those patients at lower risk than "non-switchers", and complaints about bruising or bleeding, dissatisfaction with treatment, mobility problems and anxiety/depression traits appear to be related to - and may have influenced - the choice to switch.

TL;DR: The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.

TL;DR: It is confirmed that non-anaemic HF patients with AID have poorer peak oxygen consumption, and the poorer functional evaluations in iron-deficient patients previously reported are not caused by the merging of two different populations.

TL;DR: In the acute management of submassive PE patients, a single furosemide bolus on admission seems to produce significant and earlier improvements in RV function markers compared with VE, without adverse events.